Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-09

Clinical Trial Update: Intravenous Allopurinol in Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating intravenous allopurinol in congestive heart failure has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)

Snippet

Sponsor: Johns Hopkins University | Conditions: Congestive Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2016-02-09